Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 53-59

  Castells, Lluís ^a   Vargas, Víctor ^a   Allende, Helena ^a   Bilbao, Itxarone ^a   Lázaro, José Luis ^a   Margarit, Carlos ^a   Esteban, Rafael ^a   Guardia, Jaime ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute HCV reinfection; Antiviral therapy; Hepatitis C virus; Post liver transplantation

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACUTE GRAFT REJECTION; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEPRESSION; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HEMATOLOGIC DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TIME FACTORS;

EID: 20444377637     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.02.015     Document Type: Article

References (35)

1. E. Gane The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients Liver Transpl 11 2003 S28 S34
2. M. Garcia-Retortillo, X. Forns, A. Feliu, E. Moitinho, J. Costa, and M. Navasa Hepatitis C virus kinetics during and immediately after liver transplantation Hepatology 35 2002 680 687
3. M. Prieto, M. Berenguer, J.M. Rayón, J. Córdoba, L. Argüello, and D. Carrasco High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes Hepatology 29 1999 250 256
4. L.K. Schluger, P.A. Sheiner, S.N. Thung, J.Y. Lau, A. Min, and D.C. Wolf Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation Hepatology 23 1996 971 976
5. M. Berenguer, X. López-Labrador, and T. Wright Hepatitis C and liver transplantation J Hepatol 35 2001 666 678
6. M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, and M. Rayon HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 2000 673 684
7. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, and M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
8. M. Berenguer, M. Prieto, J.M. Rayo'n, J. Mora, M. Pastor, and V. Ortiz Natural history of clinically compensated HCV-related graft cirrhosis after liver transplantation Hepatology 32 2000 852 858
9. P.S. Randhawa, and A.J. Demetris Hepatitis C virus infection in liver allografts Pathol Annu 30 1995 203 226
10. L.S. Belli, E. Silini, A. Alberti, G. Bellati, C. Vai, and E. Minola Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation Liver Transpl Surg 2 1996 200 205
11. M.W. Johnson, W.K. Washburn, R.B. Freeman, S.E. FitzMaurice, J. Dienstag, and N. Basgoz Hepatitis C viral infection in liver transplantation Arch Surg 131 1996 284 291
12. F.D. Gordon, J.J. Poterucha, J. Germer, N.N. Zein, K.P. Batts, and J.B. Gross Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation Transplantation 63 1997 1419 1423
13. C. Feray, M. Gigou, D. Samuel, V. Paradis, J. Wilber, and M.F. David The course of hepatitis C virus infection after liver transplantation Hepatology 20 1994 1137 1143
14. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, and F. Gonçales Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
15. E. Jaeckel, M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, and M. Zankel Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452 1457
16. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology 36, (2002) S3-20.
17. K. Isaac, A. Baptista, L. Bianchi, F. Callca, J. D Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
18. X. Forns, M. Garcia-Retortillo, T. Serrano, A. Feliu, F. Suarez, and M. de la Mata Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation J Hepatol 39 2003 389 396
19. G.T. Everson Treatment of patients with hepatitis C virus on the waiting list Liver Transpl 9 2003 S90 S94
20. J.P. Zarski, and M.N. Hilleret Treatment of patients with decompensated post-hepatitis C cirrhosis before liver transplantation: strategy to prevent hepatitis C virus (HCV) recurrence? J Hepatol 39 2003 435 436
21. T. Bizollon, U. Palazzo, C. Ducerf, M. Chevallier, M. Elliot, and J. Baulieus Pilot study of the combination of interferon alpha and ribavirin as therapy of recurrent hepatitis c after liver transplantation Hepatology 26 1997 500 504
22. A.B. Alberti, L.S. Belli, A. Airoldi, E. de Carlis, G. Rondinara, and L. Minola Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study Liver Transpl 7 2001 870 876
23. D.V. Gopal, J.M. Rabkin, B.S. Berk, C.L. Corless, S. Chou, and A. Olyaei Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin Liver Transpl 7 2001 181 190
24. M.E. De Vera, G.A. Smallwood, K. Rosado, L. Davis, E. Martinez, and S. Sharma Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation Transplantation 71 2001 678 686
25. M. Narayanam, J.J. Poterucha, O.M. El-Amin, L.J. Burgart, W.K. Kremers, and C.B. Rosen Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy Liver Transpl 8 2002 623 629
26. B. Lavezzo, A. Franchello, A. Smedile, E. David, A. Barbui, and M. Torrani Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus twelve months course of interferon alfa2b with ribavirin J Hepatol 37 2002 247 252
27. D. Samuel, T. Bizollon, C. Feray, B. Roche, S.N. Ahmed, and C. Lemonnier Interferon-alpha2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642 650
28. H. Rodriguez-Luna, A. Khatib, P. Sharma, G. De Petris, J.W. Williams, and J. Ortiz Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha 2b and ribavirin: an open-label series Transplantation 77 2004 190 194
29. J. Dumortier, J.Y. Scoazec, P. Chevallier, and O. Boillot Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 2004 669 674
30. J.M. Pawlotsky Use and interpretation of virological tests for hepatitis C Hepatology 36 2002 S65 S73
31. R.R. Razonable, K.W. Burak, H. Van Cruijsen, R.A. Brown, M.R. Charlton, and T.F. Smith The pathogenesis of hepatitis c virus is influenced by cytomegalovirus Clin Infect Dis 35 2002 974 981
32. M. Garcia-Retortillo, and X. Forns Prevention and treatment of hepatitis C virus recurrence after liver transplantation J Hepatol 41 2004 2 10
33. S. Vasilopoloulos, R. Hally, J. Caro, P. Martin, S. Westerberg, and M. Moritz Erythropoietin response to post-liver transplantation anemia Liver Transpl 6 2000 349 355
34. V. Vargas, R. Charco, L. Castells, R. Esteban, and C. Margarit Alpha-intereron for acute hepatitis C in liver transplant patients Transplant Proc 27 1995 1222 1223
35. D. Samuel, and C. Hepatitis Interferon, and risk of rejection after liver transplantation Liver Transpl 10 2004 868 871